ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 267 filers reported holding ALKERMES PLC in Q4 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,000 | +500.0% | 522 | +1114.0% | 0.00% | +300.0% |
| Q1 2019 | $2,000 | 0.0% | 43 | -36.8% | 0.00% | 0.0% |
| Q4 2018 | $2,000 | +100.0% | 68 | +209.1% | 0.00% | – |
| Q3 2018 | $1,000 | -75.0% | 22 | -77.1% | 0.00% | -100.0% |
| Q2 2018 | $4,000 | -69.2% | 96 | -58.6% | 0.00% | -50.0% |
| Q1 2018 | $13,000 | +30.0% | 232 | +26.1% | 0.00% | +33.3% |
| Q4 2017 | $10,000 | +400.0% | 184 | +327.9% | 0.00% | +200.0% |
| Q3 2017 | $2,000 | -89.5% | 43 | -87.6% | 0.00% | -87.5% |
| Q2 2017 | $19,000 | +111.1% | 346 | +117.6% | 0.01% | +100.0% |
| Q1 2017 | $9,000 | +80.0% | 159 | +84.9% | 0.00% | +100.0% |
| Q4 2016 | $5,000 | +400.0% | 86 | +290.9% | 0.00% | +100.0% |
| Q3 2016 | $1,000 | 0.0% | 22 | -21.4% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | -50.0% | 28 | -44.0% | 0.00% | -50.0% |
| Q1 2016 | $2,000 | -33.3% | 50 | +19.0% | 0.00% | -33.3% |
| Q4 2015 | $3,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |